Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kevin, Marley"'
Publikováno v:
Translational Oncology, Vol 8, Iss 4, Pp 231-238 (2015)
BACKGROUND: This investigation sought to elucidate the relationship between hepatocyte growth factor (HGF)–induced metastatic behavior and the tyrosine kinase inhibitors (TKIs) crizotinib and dasatinib in canine osteosarcoma (OS). Preliminary evide
Externí odkaz:
https://doaj.org/article/77118137e0a94d0d91f9f1c3dcef374e
Autor:
Shay Bracha, Cheri P. Goodall, Bernadette V. Stang, Patrick E. Chappell, Austin K. Viall, Kevin Marley
Publikováno v:
Veterinary and Comparative Oncology. 14:e31-e44
Serotonin receptor 1B (5HTR1B) traditionally exhibits anti-proliferative activity in osteoblasts. We examined the expression and function of 5HTR1B in the COS canine osteosarcoma cell line and normal canine osteoblasts. Equal levels of 5HTR1B gene an
Autor:
Bernard Séguin, Guangheng Li, Nicolle E. Hofmann, Atiya Mansoor, Shay Bracha, Charles Keller, Elaine T. Huang, Lara E. Davis, Marc M. Loriaux, Jinu Abraham, John E. Mata, Stuart C. Helfand, Kevin Marley, Jeffrey W. Tyner
Publikováno v:
Pediatric Blood & Cancer. 60:1313-1319
Osteosarcomaisthemostcommonmalignantbonetumor,yettheincidenceofosteosarcomaislowenoughtoposeasignificantbarrierto the timely completion of traditionally designed clinical trials.While research laboratories continue to investigate the underlyingmecha
Publikováno v:
Veterinary and Comparative Oncology. 10:214-222
Canine hemangiosarcoma (HSA) is an endothelial cell malignancy driven, in part, by activating mutations in receptor and non-receptor tyrosine kinases. Proteomics, Western blots and a tyrosine kinase inhibitor were used to elucidate activating mechani
Publikováno v:
Journal of Bone and Mineral Research
Chronic hyperparathyroidism (HPT) is a common cause of metabolic bone disease. These studies investigated the underlying cellular and molecular mechanisms responsible for the detrimental actions of elevated parathyroid hormone (PTH) on the skeleton.
Autor:
Brett K. Palama, Avudaiappan Maran, Sutada Lotinun, M. Zhang, Russell T. Turner, Urszula T. Iwaniec, Malcolm B. Lowry, Alexey A. Leontovich, Kristen L. Shogren, Kevin Marley
Publikováno v:
Endocrinology. 149:5735-5746
Abnormal secretion of PTH by the parathyroid glands contributes to a variety of common skeletal disorders. Prior studies implicate platelet-derived growth factor-A (PDGF-A) as an important mediator of selective PTH actions on bone. The present studie
Publikováno v:
Experimental cell research. 338(1)
Background Osteosarcoma (OS) is an aggressive and often fatal cancer that afflicts over 1000 humans and 10,000 dogs per year in the United States. Recent evidence suggests deregulation in the signaling triad, receptor activator of nuclear factor kapp
Publikováno v:
Translational Oncology
Translational Oncology, Vol 8, Iss 4, Pp 231-238 (2015)
Translational Oncology, Vol 8, Iss 4, Pp 231-238 (2015)
BACKGROUND: This investigation sought to elucidate the relationship between hepatocyte growth factor (HGF)–induced metastatic behavior and the tyrosine kinase inhibitors (TKIs) crizotinib and dasatinib in canine osteosarcoma (OS). Preliminary evide
Autor:
John E. Mata, Jennifer M. Simpson, Bernard Séguin, Kevin Marley, William G. Tracewell, Stuart C. Helfand, Shay Bracha, Lisa Brownlee
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Background Osteosarcoma in dogs and humans share many similarities and the dog has been described as an excellent model to study this disease. The median survival in dogs has not improved in the last 25 years. Taurolidine has been shown to be cytotox
Autor:
Valerie MacDonald, Jeffrey W. Tyner, Erin B. Dickerson, Vidya Schalk, Stuart C. Helfand, Wade Edris, Kevin Marley, Marc M. Loriaux, Brian J. Druker
Publikováno v:
Translational oncology. 6(2)
Hemangiosarcoma, a natural model of human angiosarcoma, is an aggressive vascular tumor diagnosed commonly in dogs. The documented expression of several receptor tyrosine kinases (RTKs) by these tumors makes them attractive targets for therapeutic in